Drug application
SULFAMETHOXAZOLE AND TRIMETHOPRIM AND PHENAZOPYRIDINE HYDROCHLORIDE (PHENAZOPYRIDINE HYDROCHLORIDE, SULFAMETHOXAZOLE, TRIMETHOPRIM)
Drugs@FDA NDA 021105 · ABLE
Key facts
| Drug name | SULFAMETHOXAZOLE AND TRIMETHOPRIM AND PHENAZOPYRIDINE HYDROCHLORIDE |
|---|---|
| Active ingredients | PHENAZOPYRIDINE HYDROCHLORIDE, SULFAMETHOXAZOLE, TRIMETHOPRIM |
| Application type | NDA |
| Application number | 021105 |
| Company | ABLE |
| Dosage forms | TABLET, ORAL |
| Strength | 200MG,N/A,N/A;N/A,800MG,160MG |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission class | Type 4 - New Combination |
| Latest submission status date | Jun 26, 2001 |
At a glance
- 1–9 Submissions
- 1–9 Label versions
- 1–9 Products
- None Therapeutic equivalents
- Yes FDA letters on file
- Yes FDA reviews on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.
Source: U.S. Food and Drug Administration (FDA), Drugs@FDA · Source date: